 |
 |
Madrid |
|
|
|
Madrid |
|
| HEADS OF THE DEPARTMENT | Prof.
Joaquín Ortuño  |
| CLINICAL STAFF | Carlos Quereda Rodríguez-Navarro, José Luis Teruel Briones, Roberto Marcén Letosa, Nieves Gallego Cobos (Pediatric Nephrology), Milagros Fernández Lucas, Ana Gonzalo Fonrodona, Fernando Liaño García, Luis Orte Martínez, Julio Pascual Santos, Maite Elisabeth Rivera Gorrín, Teresa Tenorio Cañamas (MEG), Teresa Cano Noheda (MEG) |
| RESEARCH AND LABORATORY | Josefa Sabater Lorenzo (Clinical Laboratory), Juan J. Villafruela Sanz (Research Laboratory) |
 |
|
| CONTACT
INFORMATION |
|
| jortuno.hrc@salud.madrid.org | |
| PHONE: | +91-336-8018 |
| FAX: | +91-336-8800 |
| FULL POSTAL ADDRESS | Servicio de Nefrología, Hospital Ramón y Cajal |
Ctra. Colmenar Viejo, km 9,1. E-28034 – Madrid, Spain |
|
| WEBSITE OF THE UNIT | http://www.hrc.es |
|
CLINICAL
FACILITIES |
 |
|
| NEPHROLOGY AND INTERNAL MEDICINE BEDS N° | 29 | |
| HEMODIALYSIS PATIENTS N° | 118 | |
| PERITONEAL DIALYSIS PATIENTS N° | 44 | |
| ACUTE RENAL FAILURE UNIT BEDS N° | 4 | |
| RENAL TRANSPLANTS /YEAR (2003) N° | 44 | |
| PATIENTS HOSPITALIZED IN 2003: | ||
| NEPHROLOGY DEPT: | 785 | |
| HOSPITALIZED IN OTHER AREAS | 1019 | |
| NEW OUTPATIENTS | 1323 | Chronic Hemodialysis Unit |
 |
 |
Nephrology Laboratory |
|
 |
 |
Acute Renal Failure Unit |
Nurse Station |
RESEARCH INTERESTS
CLINICAL RESEARCH
Acute renal failure:
Hemodialysis and CAPD:
Renal transplantation:
Clinical nephrology:
Arterial Hypertension:
Other:
Endothelium as endocrine and metabolic organ
Genetic basis of hypercholesterolemia
Peer Reviewed Publications in International Journals (only English) 2000-2003
Publications list
2003
| Fernández Lucas M, Quereda C ; Teruel JL; Orte L; Marcen R, Ortuño J. Effect of Hipertensión before beggining diálisis on survival of hemodiálisis patients. Am J Kidney Dis 41 : 814 – 821. 2003 |
| Pascual J, Segoloni G, González-Molina M, del castillo D, Capdevila L, Arias M, García J, Ortuño J on behalf of the Spanish-Italian Tacrolimus Study Group. Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow-up. Transplant Proc 2003;35:1701-1703. |
| Pascual J, Alarcón MC, Marcén R, Burgos FJ, Tato A, Tenorio MT, Liaño F, Ortuño J. Cytomegalovirus infection after renal transplantation: selective prophylaxis and treatment. Transplant Proc 2003;35:1756-57. |
| Pascual J, Marcén R, Burgos FJ, Tato A, Tenorio MT, Liaño F, Ortuño J. A low incidence of new-onset insulin-dependent diabetes mellitus using tacrolimus in kidney recipients in Europe. Transplant Proc 2003;35:1760-1761. |
| Burgos FJ, Pascual J, Briones G, Cuevas B, Villafruela J, Correa C, Marcén R, Gómez V. Influence of laparoscopic live donor nephrectomy in ischemia-reperfusion syndrome and renal function after kidney transplantation: an experimental study. Transplant Proc 2003;35:1664-1665. |
| Marcén R, Pascual J, Tato AM, Teruel JL, Villafruela JJ, Fernández M, Tenorio M, Burgos FJ, Ortuño J. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003;35:1714-1716. |
| Marcén R, Pascual J, Tato AM, Teruel JL, Villafruela JJ, Rivera M, Arambarri M, Burgos FJ, Ortuño J. Renal transplant recipient outcome after losing the first graft. Transplant Proc 2003;35:1679-1681. |
| Marcén R, Pascual J, Tato AM, Villafruela JJ, Teruel JL, Rivera M, Tenorio M, Fernández M, Burgos FJ, Ortuño J. Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients. Transplant Proc 2003;35:1780-1782. |
| Coronel F, Herrero JA, Montenegro J, Fernández C, Gandara A, Conesa J, Rivera M, Torrente J, Portoles J, Gómez-Martino JR. Erithropoietin requirements: a comparative multicenter study beteen peritoneal dialysis and hemodialysis. J. Nephrol 2003; 16 (5): 697-702. |
2002
| Merino JL, Rivera M, Teruel JL, Marcén R, Ortuño J. CAPD as treatment of chronic debilitating hemodialysis hypotension.Peritoneal Dialysis International 2002; 22: 429. |
| Vecino AM, Teruel JL, Navarro JL, César JM. Phosfholipase A2 activity in platelets of patients with uremia. Platelets 2002; 13 : 415-418. |
| Matesanz R, Miranda B : A decade of continuous improvement in cadaveric organ donation: The Spanish Model. Journal of Nephrology 2002, 15(1):22-28 |
| Matesanz R.: The progression of transplants in Europe. Transplant Newsletter 2002, 7(1): |
| Matesanz R.: Health systems and transplant policies. Journal of the International Society of Bioethics 2002, 8: 95-109 |
| Marcén R, Morales JM, Fernández Juárez G, Andrés A, Pascual J, Rodicio JL, Ortuño J. Risk factors of ischemic heart disease after renal transplantation. Transplant Proc 2002; 34: 394-395. |
| Fernández Juárez G, Marcén R, Pascual J, Teruel JL, Rivera ME, Villafruela JJ, Mampaso F, Burgos FJ, Ortuño J. Prolonged delayed graft function decreases graft survival in cyclosporine transplant patients. Transplant Proc 2002; 34: 338. |
| Pascual J, Marcén R, Liaño F, Ortuño J. Cadaveric kidney transplantation for the elderly. Nephron 2002;91:361-378. |
| Pascual J, Burgos FJ, Villafruela JJ, Gómez V, Cuevas B, Correa C, Marcén R, Liaño F, Mampaso F, Ortuño J. Effects of urodilatin on renal graft blood flow during ischemia-reperfusion síndrome in a pig autotransplant model. Transplant Proc 2002;34:56-57. |
| Pascual J, Ortuño J for the Spanish and Italian Tacrolimus Study Group. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy. Transplant Proc 2002;34:89-91. |
| Pascual J, Marcén R, Burgos FJ, Tenorio MT, Merino JL, Arambarri M, Villafruela JJ, Liaño F, Mampaso F, Ortuño J. One-center comparison between primary immunosuppression based on neoral cyclosporine and tacrolimus for renal transplantation. Transplant Proc 2002;34:94-95. |
| Margreiter R, for the European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group [J. Ortuño, J Pascual]. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 2002;359:741-746. |
| P. Rigotti and the European Tacrolimus/MMF Transplantation Study Group. (J. Ortuño). Patients with higt cholesterol levels benefit most from early withdrawal ol corticosteroids.Transplant Proc 2002; 34: 1797-1798. |
| K.-H Dietl for the European Renal Transplantation Study Group (J. Ortuño). Oral dosing of Tacrolimus and Cyclosporine Microemulsion-Results from a large Multicenter Study in Renal Transplantation. Transplant Proc 2002, 34: 1659-1660. |
| Montagnino G, Kramer BK, Arias M for the European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.(J. Ortuño, J. Pascual). Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in kidney transplantation: twelve-month follow-up. Transplant Proc 2002;34:1635-1637. |
2001
| Marcén R, Pascual J, Teruel JL, Villafruela JJ, Rivera ME, Mampaso F, Burgos FJ, Ortuño J. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine. Transplantation 2001; 72: 57-62. |
| Ponticelli C, Yussim A, Cambi V, Legendre C, Rizzo G, Salvadori M, Kahn D, Kashi SH, Salmela K, Fricke L, García-Martínez J, Lechler R, Heemann U, Monteon F, Ortuño J y cols. Basiliximab Singificantly Reduces Acute Rejection in Renal Transplant Patients Given Triple Therapy with Azathioprine. Transplant Proc 2001; 33: 1009-1010. |
| Mora C, Teruel JL, Navarro F. Low-density lipoprotein apheresis in homzygous familial hypercholesterolemia. Am J Cardiol 2001; 88: 202-203. |
| Gallego N, Pérez-Caballero C, Gallego A, Estepa R, Liaño F, Ortuño J. Prognosis of Patients With Acute Renal Failure Without Cardiopathy. Arch Dis Child 2001; 84:258-260 |
| Estepa R, Gallego N, Orte L, Puras E, Aracil E, Ortuño J. Renovascular Hypertension In Children Scandinavian Journal Of Urology and Nephrology 2001; 35: 388-392 |
| Alcázar JM, Marín R, Gómez-Campderá F, Orte L, Rodríguez-Jornet A and Mora-Maciá J on behalf of the Spanish Group of Ischemic Nephropathy (GEDENI): Clinical Characteristics of ischaemic renal disease. Nephrol Dial Transplant 2001; 16 (suppl 1): 74-77. |
| Matesanz R, Miranda B : Expanding the organ donor pool : The Spanish Model. Kidney Int. 2001 (59): 801-803 |
| Matesanz R.: The future Europe of Transplantation. Transplant Newsletter 2001, 6(1): 8 |
| Matesanz R.: Meeting the organ shortage: An European consensus document. Transplant Newsletter 2001, 6(1): 27 |
| Figueroa MS, Ciancas E, Mompean B, Quereda C. Treatment of multiple evanescent white dot syndrome with ciclosporine. Eur J Ophtamol 2001; 11 : 86-88. |
| Pascual J, Orte J, Marcén R, Burgos FJ, Ortuño J. Use of leflunomide in human renal transplantation. Transplantation 2001; 72: 1709-1710. |
| Pascual J, Marcén R, Ortuño J. Anti-interleukin-2 receptor antibodies: basiliximad and daclizumad. Nephrol Dial Transplant 2001; 16: 1756-1760. |
| Estepa R, Gallego N, Orte L, Belanger A, Aracil E, Ortuño J. Pediatric Renovascular Hypertension. Ped. Nephrol 2001; 16:529-530. |
| Gallego N, Estepa R, Tellería D, San Millán JL, Belanger A, Ortuño J.Angiotensin I Converting Enzyme Gene Polimorphism And Reflux Nephropathy In Children.Nephron 2001;89:231-232. |
European
Fellows programme
Specify
if the Unit accepts fellows from European countries for:
Short (1-2 month) well focused training programs either clinically or
laboratory oriented: Yes
Long (at least 1 year) research fellowships: Yes.
Specify corresponding availability of grants: No.
Specify if the Unit may provide help for accommodation: No.
Prerequisites for Fellowship
Language: Spanish, English.
Work/Research experience as resident